Polymorphism of alpha-1-antitrypsin in hematological malignancies

Polymorphism of alpha-1-antitrypsin in hematological malignancies

Alpha-1-antitrypsin (AAT) or serine protease inhibitor A1 (SERPINA1) is an important serine protease inhibitor in humans. The main physiological role of AAT is to inhibit neutrophil elastase (NE) released from triggered neutrophils, with an additional lesser role in the defense against damage inflic...

Full description

Bibliographic Details
Main Authors:	Aleksandra Topic, Zorica Juranic, Svetislav Jelic, Ivana Golubicic Magazinovic
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Genética 2009-01-01
Series:	Genetics and Molecular Biology
Subjects:	Alpha-1-antitrypsin polymorphism lymphomas
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572009000400008

Similar Items

Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
by: Bebiana Conde, et al.
Published: (2022-07-01)

PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)

The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
by: Dawid Kościołek, et al.
Published: (2024-02-01)

Alpha-1 antitrypsin gene polymorphism in Chronic Obstructive Pulmonary Disease (COPD)
by: Sabri Denden, et al.
Published: (2010-01-01)

The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry
by: Tobias Meischl, et al.
Published: (2023-01-01)

Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review
by: Ilaria Ferrarotti, et al.
Published: (2024-02-01)

Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0RİZE
by: Dilek Karadoğan, et al.
Published: (2024-02-01)

Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic
by: Herth FJF, et al.
Published: (2021-11-01)

Assessing Patients with Alpha-1 Antitrypsin Deficiency for Corneal Refractive Surgery: A Review and Clinical Experience
by: Majid Moshirfar, et al.
Published: (2022-07-01)

Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites
by: I. Suárez-Lorenzo, et al.
Published: (2018-11-01)

Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01)

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
by: Emanuel Buck, et al.
Published: (2022-01-01)

Effect of alpha-1antitrypsin,adiponectine,leptein in obesity
by: Halla G. Mahmood
Published: (2014-01-01)

Alpha-1 antitrypsin deficiency: outstanding questions and future directions
by: María Torres-Durán, et al.
Published: (2018-07-01)

Long-term augmentation therapy with Alpha-1 Antitrypsin in an MZ-AAT severe persistent asthma
by: I. Blanco, et al.
Published: (2016-01-01)

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
by: Dunlea DM, et al.
Published: (2018-03-01)

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
by: Marc Miravitlles, et al.
Published: (2022-12-01)

Isoelectrofocusing and PCR amplification-reverse hybridization assay in evaluation of alpha-1-antitrypsin deficiency
by: Beletić Anđelo, et al.
Published: (2009-01-01)

Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil
by: Rodrigo Russo, et al.

The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil
by: Manuela Brisot Felisbino, et al.

The Study of Alterations of alpha – 1 – Antitrypsin (1-AT) in Serum of Hypothyroid Patients
by: Alireza Kheirollah, et al.
Published: (1998-09-01)

Evaluation of Alpha-1 Antitrypsin Level in the Serum of Children With Idiopathic Bronchiectasis
by: Maryam Babaei, et al.
Published: (2021-11-01)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01)

Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History
by: Simona Viglio, et al.
Published: (2020-09-01)

A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application
by: Michael E. O’Brien, et al.
Published: (2022-02-01)

Alpha 1 antitrypsin deficiency in non cystic fibrosis bronchiectasis
by: Mohamed Shahat Badawy, et al.
Published: (2013-04-01)

Associations of Polymorphism of rs9944155, rs1051052, and rs1243166 Locus Allele in Alpha-1-antitrypsin with Chronic Obstructive Pulmonary Disease in Uygur Population of Kashgar Region
by: Xue-Mei Zhong, et al.
Published: (2018-01-01)

Future Perspectives in the Diagnosis and Treatment of Liver Disease Associated with Alpha-1 Antitrypsin Deficiency
by: Nélia Abreu, et al.
Published: (2023-02-01)

Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients
by: Nygren D, et al.
Published: (2022-06-01)

Cellular Consequences of Z Alpha-1 Antitrypsin Accumulation and Prospects for Therapy
by: Sam Alam, et al.
Published: (2013-12-01)

Structural characterization and conformational dynamics of alpha-1 antitrypsin pathogenic variants causing alpha-1-antitrypsin deficiency
by: Noor Ahmad Shaik, et al.
Published: (2022-11-01)

Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life
by: Beiko T, et al.
Published: (2019-07-01)

The Course of AαVal541 as a Proteinase 3 Specific Neo-Epitope after Alpha-1-Antitrypsin Augmentation in Severe Deficient Patients
by: Iris G. M. Schouten, et al.
Published: (2021-07-01)

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence
by: Franck F. Rahaghi, et al.
Published: (2017-05-01)

Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli
by: Marco Mosella, et al.
Published: (2018-01-01)

Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches
by: Simona Viglio, et al.
Published: (2021-01-01)

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
by: Robert A. Stockley, et al.
Published: (2023-08-01)

Comparison The Activity Rate of Alpha-1 Antitrypsin in Obese with normal weight People
by: farzad roshanzamir, et al.
Published: (2014-05-01)

Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review
by: Edgar RG, et al.
Published: (2017-05-01)

In silico analysis of alpha1-antitrypsin variants: the effects of a novel mutation
by: Sabri Denden, et al.
Published: (2010-01-01)